Managing Laboratory Quality Control

1. Analyte/test system — Which test or instrument is being monitored? Default: chemistry analyzer, general chemistry panel.
2. QC material — What levels are run (Level 1/low, Level 2/normal, Level 3/high)? Default: two levels per CLIA minimum.
3. QC frequency — When are QC materials run (each shift, daily, each analytical run, weekly)? Default: at minimum once per 24 hours per CLIA.
4. QC rule set — Which Westgard rules are applied (1-2s warning, 1-3s, 2-2s, R-4s, 4-1s, 10x)? Default: standard Westgard multi-rule.
5. Current issue — Is this routine QC review, a specific violation investigation, or method validation QC establishment? Default: routine review.
6. Peer group data — Are CAP proficiency testing or AACC peer group statistics available? Default: CAP survey results on file.
7. EQC/IQCP status — Is this test system on an Individualized Quality Control Plan (IQCP) or standard QC? Default: standard QC.

Documents to Request

• Levey-Jennings charts for the past 30-60 days
• Current mean and SD values for each QC level
• Westgard rule violation log with corrective action documentation
• Manufacturer QC ranges and acceptable limits
• CAP peer group statistics for the analyte
• Instrument maintenance and calibration logs
• IQCP risk assessment (if applicable)
• Previous CAP/CLIA inspection findings related to QC

Step 1: Establishing QC Parameters

Set up or verify QC statistical parameters for each analyte:

1. Target mean: Calculated from at least 20 data points (preferably 20 independent runs over 20+ days per CLSI C24-A4).
2. Standard deviation (SD): Calculate from the same 20+ data points. Assess for outliers using Dixon or Grubbs test before finalizing.
3. Coefficient of variation (CV): CV% = (SD/Mean) x 100. Compare to manufacturer claims, CLIA allowable total error (TEa), and CAP peer group CV.
4. Control limits: Set at mean +/- 2SD (warning) and mean +/- 3SD (rejection).

Step 2: Applying Westgard Multi-Rules

Apply the Westgard multi-rule algorithm to each QC run:

Decision tree for violations:

1. 1-2s triggered → Inspect Levey-Jennings chart for trends. Do NOT reject patient results. Continue monitoring.
2. 1-3s, 2-2s, R-4s, 4-1s, or 10x triggered → REJECT the analytical run. Hold all patient results from that run. Investigate root cause. Repeat QC after corrective action.
3. Corrective action succeeds (QC in range) → Release patient results from the new run only.
4. Corrective action fails → Escalate per institutional protocol (supervisor, service engineer, laboratory director).

Step 3: Root Cause Investigation and Corrective Action

When a Westgard rule violation occurs, investigate systematically:

Immediate actions:

• Repeat the QC with a fresh aliquot of the same QC lot.
• If still out, try a new vial of QC material (rule out QC material degradation).
• Check reagent expiration dates, lot numbers, and storage conditions.
• Review instrument maintenance logs for pending or overdue maintenance.

Root cause categories:

Documentation requirements (per CAP GEN.20375):

• Date and time of violation
• Westgard rule triggered
• QC values and control limits
• Investigation steps performed
• Root cause identified (or "no assignable cause" if resolved by repeat)
• Corrective action taken
• Follow-up QC results confirming resolution
• Impact assessment on patient results (were any patient results reported during the out-of-control period?)

Step 4: Levey-Jennings Chart Review and Trend Analysis

Perform regular (at minimum monthly) review of Levey-Jennings charts:

• Shifts: Six or more consecutive points on one side of the mean indicate a systematic change. Investigate even if within 2SD.
• Trends: Six or more consecutive points moving in one direction (up or down) indicate a progressive systematic error.
• Increasing SD: Compare monthly CV to the established CV. An increasing CV may indicate reagent degradation, instrument aging, or loss of precision.
• Mean migration: Compare monthly means to the established mean and to CAP peer group means. Drift may indicate calibration issues.

Document the review with: reviewer name, date, time period reviewed, findings, and any actions taken.

Step 5: QC Program Reporting and Compliance

Generate QC compliance reports for laboratory leadership:

1. Monthly QC summary: Number of runs, number of violations by rule, corrective actions, resolution status.
2. Analyte-specific trending: CV% over time, mean stability, bias vs. peer group.
3. Turnaround for corrective actions: Time from violation to resolution.
4. Patient impact assessment: Number of patients potentially affected by out-of-control results and notification status.
5. Regulatory readiness: Compliance with CLIA QC frequency requirements, CAP checklist items, and IQCP documentation (if applicable).

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Are QC means and SDs based on at least 20 independent data points per CLSI C24-A4?
2. Is every Westgard rule violation documented with root cause investigation and corrective action?
3. Were patient results from out-of-control runs assessed for impact and recollected/re-run if necessary?
4. Are Levey-Jennings charts reviewed at least monthly with documented reviewer sign-off?
5. Does the QC program meet CLIA minimum frequency requirements (at minimum two levels per 24 hours for non-waived testing)?

Quality Audit

• QC means and SDs established from minimum 20 data points
• Two levels of QC run at minimum per 24 hours per CLIA requirements
• Westgard multi-rule algorithm applied consistently to all QC data
• 1-2s used as warning only; no patient results rejected on 1-2s alone
• All 1-3s, 2-2s, R-4s, 4-1s, 10x violations documented with corrective action
• Root cause investigation documented for every out-of-control event
• Patient result impact assessment performed for every out-of-control run
• Levey-Jennings charts reviewed monthly with signed documentation
• QC material storage conditions monitored and documented
• Reagent and calibrator lot changes documented with crossover QC
• CV% compared to manufacturer claims and CAP peer group statistics
• IQCP risk assessment current (if applicable)
• QC records available for CAP/CLIA inspection (minimum 2-year retention)

Guidelines

• Never release patient results from a run that failed a Westgard rejection rule (1-3s, 2-2s, R-4s, 4-1s, 10x) until the cause is resolved and QC passes
• The 1-2s rule is a WARNING only; it is not a rejection rule and should not trigger corrective action unless it occurs in conjunction with other rules
• When a new QC lot is introduced, run the old and new lots in parallel for at least 5 days (20 data points) to establish the new mean and SD before using the new lot for patient result validation
• Document every corrective action with enough detail that a CAP inspector can reconstruct the investigation from the written record
• Review Levey-Jennings charts at least monthly and look for shifts (6 consecutive same-side) and trends (6 consecutive directional) even when no rejection rules are triggered
• Compare your laboratory's CV% and bias to CAP peer group statistics at least semi-annually; persistent outlier performance requires method review
• Maintain all QC records for a minimum of 2 years per CLIA retention requirements; CAP recommends retention for the life of the instrument
• For tests on IQCP (Individualized Quality Control Plan), ensure the risk assessment is reviewed annually and updated when changes occur to personnel, environment, reagents, or specimen types